Virax Biolabs Ltd.

Based in Scotland, Virax Biolabs supply high performance assays and reagents designed to accelerate the study of antigen-specific immune responses. Alongside our product range, we provide a variety of immunology lab services. Our team has experience in a range of advanced analytical techniques, such as ELISA, ELISpot, FluoroSpot, and flow cytometry assays. We also offer a range of tailored services with expertise in recombinant antibody and protein/peptide production, as well as protein sequencing and antibody engineering.

Virax is also advancing ViraxImmune™, an in-development T cell immune-profiling platform, with current development focusing on post-acute infection syndromes including Long COVID and ME/CFS. ViraxImmune™ is being evaluated as a potential aid to clinical assessment by identifying a defined T cell immune-response profile associated with the target population. Final intended use, target population, performance claims and regulatory pathway remain subject to ongoing development, validation and regulatory review.